Specifically Targeted Modification of Human Aldose Reductase by Physiological Disulfides
1996 · Journal of Biological Chemistry · 66 citations
https://doi.org/10.1074/jbc.271.52.33539
M
Massimo Dal Monte
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
211
Papers
4.3K
Citations
40
h-index
106
i10-index
Massimo Dal Monte is an academic researcher from University of Pisa. The author has contributed to research in topics: Retinal Diseases and Treatments & Retinopathy of Prematurity Studies & Retinal Development and Disorders. The author has an h-index of 40, co-authored 180 publications.
ORCID: 0000-0002-5181-4456Papers by this author
worksStudy protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491
2010 · BMC Pediatrics · 56 citations
https://doi.org/10.1186/1471-2431-10-83
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function
2016 · Kidney International · 44 citations
https://doi.org/10.1016/j.kint.2016.03.020
Morpho-functional analysis of the early changes induced in retinal ganglion cells by the onset of diabetic retinopathy: The effects of a neuroprotective strategy
2022 · Pharmacological Research · 38 citations
https://doi.org/10.1016/j.phrs.2022.106516
Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen‐induced retinopathy: beneficial effect of the absence of AQP4
2017 · Journal of Cellular and Molecular Medicine · 35 citations
https://doi.org/10.1111/jcmm.13348
The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
2023 · Pharmacological Research · 21 citations
https://doi.org/10.1016/j.phrs.2023.106713
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat